Form 4: Sanara MedTech Executive Settles Tax Obligations with Stock

Sentiment:

SEC Form 4


Seth D. Yon, a top executive at Sanara MedTech, used company stock to cover tax obligations arising from vested restricted stock.

Summary

  • On May 15, 2025, Seth D. Yon, President & Chief Commercial Officer of Sanara MedTech Inc., had 4,929 shares of common stock withheld by the company to cover tax obligations.
  • This withholding was related to the vesting of 13,465 shares of restricted stock granted to Yon on May 15, 2024.
  • The price per share used for the transaction was $30.88.
  • Following the transaction, Yon directly owns 61,288 shares of Sanara MedTech Inc.

Sentiment

Score: 5

Explanation: Neutral. This is a standard transaction related to executive compensation and tax obligations.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Key Dates

DateDescription
05/15/2024Date of grant of 13,465 shares of restricted stock to Seth D. Yon
05/15/2025Date of stock withholding transaction to cover tax obligations
05/16/2025Date of Form 4 signature

Keywords

Sanara MedTech, SMTI, Seth D. Yon, stock withholding, Form 4, executive compensation, restricted stock, tax obligations, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.